# EktoTherix™ Regenerative Tissue Scaffold for Repair of Surgical Excision Wounds

> **NCT02409628** · NA · COMPLETED · sponsor: **Neotherix Limited** · enrollment: 12 (actual)

## Conditions studied

- Non-melanoma Skin Cancer
- Basal Cell Carcinoma
- Squamous Cell Carcinoma

## Interventions

- **DEVICE:** EktoTherix

## Key facts

- **NCT ID:** NCT02409628
- **Lead sponsor:** Neotherix Limited
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04-23
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-09-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02409628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02409628, "EktoTherix™ Regenerative Tissue Scaffold for Repair of Surgical Excision Wounds". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02409628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*